SCHEMBL16626448

SCHEMBL16626448

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Nc3c(F)c(F)c(C(F)(F)F)c(F)c3F)ccc12

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IDE P14735 1/20 0.36
HTR6 P50406 5/20 0.35
KMT2A Q03164 1/20 0.35
TSHR P16473 1/20 0.33
RORC P51449 2/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP3A5 P20815 1/20 0.33
S1PR1 P21453 1/20 0.33
NAMPT P43490 2/20 0.32
METAP2 P50579 1/20 0.32
TBXAS1 P24557 1/20 0.32
CNR2 P34972 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16618794 0.99 IDE (0.36) IDEHTR6KMT2ATSHRRORC
SCHEMBL17971533 0.91 IDE (0.37) IDEHTR6PDE4APDE4BPDE4C
SCHEMBL17971532 0.90 IDE (0.38) IDEHTR6PDE4APDE4BPDE4C
Hydrochloric Acid SCHEMBL16618785 0.89 IDE (0.37) IDEHTR6PDE4APDE4BPDE4C
SCHEMBL17971528 0.87 IDE (0.38) IDEHTR6KMT2APDE4APDE4B
SCHEMBL16626388 0.87 HTR6 (0.40) IDEHTR6KMT2ATSHRCYP3A4
SCHEMBL16626729 0.87 IDE (0.36) IDEHTR6PDE4APDE4BPDE4C
Hydrochloric Acid SCHEMBL16619158 0.86 HTR6 (0.39) IDEHTR6KMT2ATSHRCYP3A4
SCHEMBL16626705 0.86 IDE (0.38) IDEHTR6PDE4APDE4BPDE4C
Hydrochloric Acid SCHEMBL16618777 0.86 IDE (0.38) IDEHTR6KMT2APDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI IDE 2586/4885HTR6 166/4885KMT2A 3300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.